ANAVEX LIFE SCIENCES CORP. Revenue from Grants (Deprecated 2018-01-31)
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Revenue from Grants (Deprecated 2018-01-31) of $47.77 thousand for the 3-month period ending 2016-06-30, per its 10-Q filed 2016-08-11.
Discontinued › Income Statement › Other Income
us-gaap:RevenueFromGrants · last filed 2016-08-11
- ANAVEX LIFE SCIENCES CORP. revenue from grants (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $47.77K.
- ANAVEX LIFE SCIENCES CORP. revenue from grants (deprecated 2018-01-31) for the quarter ending 2016-03-31 was $26.88K.
- ANAVEX LIFE SCIENCES CORP. revenue from grants (deprecated 2018-01-31) for the quarter ending 2015-12-31 was $610.15K.
| Period end | Revenue from Grants (Deprecated 2018-01-31) 3 month | Revenue from Grants (Deprecated 2018-01-31) 6 month | Revenue from Grants (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2016-06-30 | $47.77K 10-Q · filed 2016-08-11 | $74.65K derived: sum of 2 quarters · filed 2016-08-11 | $684.79K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $26.88K 10-Q · filed 2016-05-11 | $637.03K 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $610.15K 10-Q · filed 2016-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |